Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Drug

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Going Home (A short film on Dementia)

reconceptualization1 - wernicke-korsakoff syndrome15 - memory restoration1 - miller fisher1 - gradual degeneration1 - pdad1 - low-density lipoprotein receptor-related protein 61 - bapineuzumab1 - people with dementia4 - mild alzheimer's stage1 - white matter hyperintensities1 - huntingtons disease4 - huntington's disease8 - blood markers1 - alzheimer's disease risk3 - physical function1 - inflammation1 - common form of dementia1 - gammagard1 - anoea1 - microrna1 - arts health institute1 - early-stage parkinsons1 - carotid ultrasound1 - kraepelin3 - metabolic syndrome1 - ßsecretase-11 - trigger for alzheimer's1 - dopamine6 - dementia community1 -